• MS pipeline for biologically active substances developed
    A coherent pipeline for MS analysis of biologically active substances has been devised

Bioanalytical

MS pipeline for biologically active substances developed

A mass spectrometry (MS) pipeline designed to facilitate the analysis of biologically active substances has been developed by scientists.

The team from the UK Health Protection Agency worked to create the first coherent pipeline for the process, with their findings published in the latest issue of BMC Bioinformatics.

While MS has been indicated as a suitable way to discover novel biomarkers in the past, the scientists argue that no cohesive procedure has been in place for doing so.

Now they have devised a four-stage approach, beginning with a sample preparation phase.

The MS analysis itself forms the second part of the process, while in the third phase databases are searched using the outcomes of the spectrometry.

Finally, the appropriate biomarkers are validated, a stage the researchers say is "vital for discovery of robust biomarkers".

BMC Bioinformatics is peer-reviewed and published online with open access, covering topics such as statistical and computational methods for analysing biologically active substances.

Events

ACS National Meeting - Fall 2025

Aug 17 2025 Washington DC, USA & Virtual

MC 2025

Aug 31 2025 Karlsruhe, Germany

CE Pharm 2025

Sep 07 2025 Rockville, MD

BMSS Annual Meeting 2025

Sep 08 2025 Edinburgh, UK

International Reid Bioanalytical Forum

Sep 08 2025 Cambourne, UK

View all events